TY  - JOUR
T1  - IS insulin the preferred compound in lowering glucose levels in patients after a myocardial infarction?
AU  - Rensing KL, Kastelein JP, Twickler M
Y1  - 2009/09/28
N1  - 10.1001/archinternmed.2009.326
JO  - Archives of Internal Medicine
SP  - 1633
EP  - 1638
VL  - 169
IS  - 17
N2  - 

			Looking at their interesting observations, we wonder whether insulin should be used as the preferable compound to lower glucose levels. From Figure 2 of their article,1 the in-hospital mortality appeared to be more pronounced in patients who were treated with insulin (although not significant) compared with non–insulin-treated patients. This trend was present along almost all glucose level intervals. Therefore, these results might suggest a less beneficial outcome in those hyperglycemic patients treated with insulin.
		

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2009.326
UR  - http://dx.doi.org/10.1001/archinternmed.2009.326
ER  -